Rare and Orphan Diseases

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Purpose at the Center: Craig Martin’s “Rare” Commitment to Biopharma and Patients

Biotech Without Borders: Reclaiming the Wonder of Science in a Distracted Age

Real-World Evidence Unlocks Consumer Voice to Improve Care

2024 Health Trends: Progress, Challenges, and Opportunities

LATEST

TRENDING

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

Rare – Always Present and Never Forgotten

The Disorder That Makes Monster Faces Out of Everyone You See

Looking for Zebras: Listening to Patients, Healing the Health System

2024 Health Trends: Progress, Challenges, and Opportunities

Real-World Evidence Unlocks Consumer Voice to Improve Care

India’s Pivotal Regulatory Shift: A Possible Game-Changer in Expediting Medicines to Millions in Dire Need

Hair Loss: The Hidden Toll of Stress

It’s Time to Reconsider Deadly Munchausen’s Syndrome by Proxy

Invisible Disabilities Need Our Attention and Understanding Like No Others

EDITORS CHOICE

Real-World Evidence Unlocks Consumer Voice to Improve Care

It’s Time to Reconsider Deadly Munchausen’s Syndrome by Proxy

2024 Health Trends: Progress, Challenges, and Opportunities

Reevaluating Ehlers-Danlos Syndrome: How Vascular EDS Patients Are Left Behind

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories